Clinical Drug Experience Knowledgebase

Acute Disease (Phase 2)

Adenocarcinoma (Phase 2)

Adenocarcinoma, Bronchiolo-Alveolar (Phase 2)

Adenocarcinoma of Lung (Phase 2)

Amyloidosis (Phase 2)

Anemia (Phase 2)

Anemia, Hemolytic (Phase 2)

Anemia, Hemolytic, Autoimmune (Phase 2)

Anemia, Refractory (Phase 2)

Anemia, Refractory, with Excess of Blasts (Phase 2)

Anemia, Sickle Cell (Phase 1)

Astrocytoma (Phase 1)

Bile Duct Neoplasms (Phase 1)

Blast Crisis (Phase 2)

Brain Neoplasms (Phase 1)

Breast Carcinoma In Situ (Phase 3)

Breast Neoplasms (Phase 3)

Breast Neoplasms, Male (Phase 2)

Burkitt Lymphoma (Phase 2)

Calcinosis (Phase 1)

Carcinoma (Phase 3)

Carcinoma, Acinar Cell (Phase 1)

Carcinoma, Ductal, Breast (Phase 3)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma in Situ (Phase 3)

Carcinoma, Intraductal, Noninfiltrating (Phase 3)

Carcinoma, Lobular (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Carcinoma, Small Cell (Phase 1)

Carcinoma, Squamous Cell (Phase 2)

Carcinoma, Transitional Cell (Phase 2)

Central Nervous System Neoplasms (Phase 2)

Cholangiocarcinoma (Phase 1)

Chondrosarcoma (Phase 2)

Colonic Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 2)

Cytomegalovirus Infections (Phase 2)

Desmoplastic Small Round Cell Tumor (Phase 2)

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 1 (Phase 2)

Disease (Phase 2)

Endometrial Neoplasms (Phase 2)

Enteropathy-Associated T-Cell Lymphoma (Phase 2)

Ependymoma (Phase 1)

Esophageal Neoplasms (Phase 2)

Esophageal Squamous Cell Carcinoma (Phase 2)

Fallopian Tube Neoplasms (Phase 2)

Fractures, Stress (Phase 2)

Gallbladder Neoplasms (Phase 1)

Glioblastoma (Phase 2)

Glioma (Phase 1)

Gliosarcoma (Phase 1)

Graft vs Host Disease (Phase 2)

Head and Neck Neoplasms (Phase 2)

Heart Failure (Phase 2)

Hemangiopericytoma (Phase 1)

Hematologic Diseases (Phase 2)

Hematologic Neoplasms (Phase 1)

Hemoglobinopathies (Phase 1)

Hemolysis (Phase 2)

Hepatitis C (Phase 4)

Hodgkin Disease (Phase 2)

Hypereosinophilic Syndrome (Phase 1)

Hyperplasia (Phase 3)

Immunoblastic Lymphadenopathy (Phase 2)

Infections (Phase 3)

Inflammatory Breast Neoplasms (Phase 2)

Intestinal Diseases (Phase 2)

Intestinal Neoplasms (Phase 2)

Intraocular Lymphoma (Phase 1)

Kidney Neoplasms (Phase 2)

Laboratory Infection (Phase 2)

Leukemia (Phase 2)

Leukemia, Biphenotypic, Acute (Phase 2)

Leukemia, Erythroblastic, Acute (Phase 1)

Leukemia, Hairy Cell (Phase 2)

Leukemia, Large Granular Lymphocytic (Phase 1)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia-Lymphoma, Adult T-Cell (Phase 2)

Leukemia, Megakaryoblastic, Acute (Phase 1)

Leukemia, Monocytic, Acute (Phase 1)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Accelerated Phase (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Leukemia, Myelomonocytic, Acute (Phase 2)

Leukemia, Myelomonocytic, Chronic (Phase 2)

Leukemia, Myelomonocytic, Juvenile (Phase 2)

Leukemia, Plasma Cell (Phase 2)

Leukemia, Prolymphocytic (Phase 1)

Leukemia, Prolymphocytic, B-Cell (Phase 1)

Leukemia, Promyelocytic, Acute (Phase 2)

Leukemia, T-Cell (Phase 2)

Liposarcoma (Phase 2)

Liver Diseases (Phase 1)

Liver Neoplasms (Phase 2)

Lung Neoplasms (Phase 2)

Lymphadenopathy (Phase 2)

Lymphedema (Phase 2)

Lymphoma (Phase 3)

Lymphoma, B-Cell (Phase 3)

Lymphoma, B-Cell, Marginal Zone (Phase 2)

Lymphoma, Extranodal NK-T-Cell (Phase 1)

Lymphoma, Follicular (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 3)

Lymphoma, Large-Cell, Anaplastic (Phase 2)

Lymphoma, Large-Cell, Immunoblastic (Phase 1)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 3)

Lymphoma, T-Cell (Phase 2)

Lymphoma, T-Cell, Cutaneous (Phase 2)

Lymphoma, T-Cell, Peripheral (Phase 2)

Lymphomatoid Granulomatosis (Phase 1)

Lymphoproliferative Disorders (Phase 2)

Mastocytosis (Phase 2)

Mastocytosis, Systemic (Phase 2)

Medulloblastoma (Phase 1)

Melanoma (Phase 2)

Meningeal Neoplasms (Phase 1)

Meningioma (Phase 1)

Mesothelioma (Phase 2)

Monoclonal Gammopathy of Undetermined Significance (Phase 1)

Multiple Myeloma (Phase 3)

Mycoses (Phase 2)

Mycosis Fungoides (Phase 2)

Myelodysplastic-Myeloproliferative Diseases (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Myeloproliferative Disorders (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasm, Residual (Phase 1)

Neoplasms (Phase 3)

Neoplasms, Germ Cell and Embryonal (Phase 3)

Neoplasms, Plasma Cell (Phase 3)

Neoplasms, Second Primary (Phase 1)

Nervous System Neoplasms (Phase 2)

Neuroblastoma (Phase 2)

Neuroectodermal Tumors, Primitive (Phase 1)

Neuroectodermal Tumors, Primitive, Peripheral (Phase 2)

Neurotoxicity Syndromes (Phase 2)

Neutropenia (Phase 2)

Oligodendroglioma (Phase 1)

Osteosarcoma (Phase 2)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 2)

Panniculitis (Phase 2)

Paraproteinemias (Phase 1)

Pelvic Neoplasms (Phase 2)

Penile Neoplasms (Phase 1)

Peritoneal Neoplasms (Phase 1)

Philadelphia Chromosome (Phase 2)

Plasmablastic Lymphoma (Phase 1)

Plasmacytoma (Phase 2)

Pleural Effusion (Phase 1)

Pleural Effusion, Malignant (Phase 1)

Polycythemia (Phase 1)

Polycythemia Vera (Phase 1)

Precancerous Conditions (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Preleukemia (Phase 2)

Primary Myelofibrosis (Phase 2)

Prostatic Neoplasms (Phase 2)

Rectal Neoplasms (Phase 2)

Recurrence (Phase 1)

Sarcoma (Phase 2)

Sarcoma, Ewing (Phase 2)

Scleroderma, Diffuse (Phase 1)

Scleroderma, Systemic (Phase 1)

Sclerosis (Phase 2)

Sezary Syndrome (Phase 2)

Skin Neoplasms (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Smoldering Multiple Myeloma (Phase 2)

Spinal Cord Neoplasms (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 1)

Stomach Neoplasms (Phase 2)

Syndrome (Phase 2)

Teratoma (Phase 2)

Testicular Neoplasms (Phase 3)

Thalassemia (Phase 1)

Thrombocythemia, Essential (Phase 1)

Thrombocytopenia (Phase 2)

Thrombocytosis (Phase 1)

Thymoma (Phase 2)

Thymus Neoplasms (Phase 2)

Triple Negative Breast Neoplasms (Phase 2)

Ureteral Neoplasms (Phase 2)

Urethral Neoplasms (Phase 2)

Urinary Bladder Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 1)

Uterine Neoplasms (Phase 1)

Ventricular Remodeling (Phase 2)

Viremia (Phase 2)

Vitamin D Deficiency (Phase 2)

Waldenstrom Macroglobulinemia (Phase 1)